UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  FORM 10-KSB/A

[ X ] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
ACT OF 1934

For the fiscal year ended December 31, 2004

Or

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
ACT OF 1934

For the transition period from                         to
                                ----------------------    ---------------------

                         Commission File Number: 0-26027

                                DATIGEN.COM, INC.
              ----------------------------------------------------
             (Exact name of registrant as specified in its charter)

                 Utah                      87-0626333
        ---------------------------                 -------------------
        (State or other jurisdiction                (IRS Employer
        of incorporation)                           Identification No.)

                                207 Piaget Avenue
                            Clifton, New Jersey 07011
                    (Address of principal executive offices)

                                 (973) 340-6000
                    (Registrant's telephone number, including
                                   area code)

Securities registered pursuant to Section 12(b) of the Act: None

Securities registered pursuant to section 12(g) of the Act: Common Stock, no par
value

      Indicate by check mark whether the company (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Exchange Act during the past
12 months (or for such shorter period that the company was required to file such
reports), and (2) has been subject to such filing requirements for the past 90
days.

<PAGE>

                  Yes      [ X ]    No      [   ]

      Indicate by check mark if there is disclosure of delinquent filers in
response to Item 405 of Regulation S-K is not contained in this form, and no
disclosure will be contained, to the best of company's knowledge, in definitive
proxy or information statements incorporated by reference in Part III of this
Form 10-KSB or any amendment to this Form 10-KSB. [ ]

      Indicate by check mark whether the company is an accelerated filer (as
defined in Rule 12b-2 of the Act) [ ] Yes [ X ] No

      The Company's revenues for its most recent fiscal year were $643,226.

      Based on the closing sales price of the Common Stock on April 5, 2005, the
aggregate market value of the voting stock of the company held by non-affiliates
was $22,047,383.40.

      The Company has 38,476,189 shares of common stock outstanding as of April
4, 2005.

      Documents Incorporated By Reference: None

      Transitional Small Business Issuer Disclosure Format (check one): Yes [ ]
No [ X ].


                                       ii
<PAGE>




                                EXPLANATORY NOTE

WE ARE FILING THIS AMENDMENT NO. 1 TO OUR ANNUAL REPORT ON FORM 10-KSB FOR THE
YEAR ENDED DECEMBER 31, 2004 TO RESPOND TO CERTAIN COMMENTS RECEIVED BY US FROM
THE STAFF OF THE SECURITIES AND EXCHANGE COMMISSION. OUR FINANCIAL POSITION AND
RESULTS OF OPERATIONS FOR THE PERIODS PRESENTED HAVE NOT BEEN RESTATED FROM THE
FINANCIAL POSITION AND RESULTS OF OPERATIONS ORIGINALLY REPORTED.

FOR CONVENIENCE AND EASE OF REFERENCE, WE ARE ONLY FILING THE SECTIONS OF THE
ANNUAL REPORT WITH THE APPLICABLE CHANGES. ACCORDINGLY, THIS AMENDMENT NO. 1 TO
OUR ANNUAL REPORT SHOULD BE READ IN CONJUNCTION WITH THE ANNUAL REPORT FILED
WITH THE SEC ON APRIL 11, 2005 AND WITH OUR SUBSEQUENT FILINGS WITH THE SEC.

FORWARD-LOOKING STATEMENTS

      This Annual Report on Form 10-KSB/A contains forward-looking information.
Forward-looking information includes statements relating to future actions,
prospective products, future performance or results of current or anticipated
products, sales and marketing efforts, costs and expenses, interest rates,
outcome of contingencies, financial condition, results of operations, liquidity,
business strategies, cost savings, objectives of management of Datigen.com, Inc.
(the "Company") and other matters. The Private Securities Litigation Reform Act
of 1995 provides a "safe harbor" for forward-looking information to encourage
companies to provide prospective information about themselves without fear of
litigation so long as that information is identified as forward-looking and is
accompanied by meaningful cautionary statements identifying important factors
that could cause actual results to differ materially from those projected in the
information. Forward-looking information may be included in this Annual Report
on Form 10-KSB/A or may be incorporated by reference from other documents filed
with the Securities and Exchange Commission (the "SEC") by the Company. You can
find many of these statements by looking for words including, for example,
"believes," "expects," "anticipates," "estimates" or similar expressions in this
Annual Report on Form 10-KSB/A or in documents incorporated by reference in this
Annual Report on Form 10-KSB/A. The Company undertakes no obligation to publicly
update or revise any forward-looking statements, whether as a result of new
information or future events.

      The Company has based the forward-looking statements relating to the
Company's operations on management's current expectations, estimates and
projections about the Company and the industry in which it operates. These
statements are not guarantees of future performance and involve risks,
uncertainties and assumptions that we cannot predict. In particular, we have
based many of these forward-looking statements on assumptions about future
events that may prove to be inaccurate. Accordingly, the Company's actual
results may differ materially from those contemplated by these forward-looking
statements. Any differences could result from a variety of factors, including,
but not limited to the following:

                                       1

<PAGE>


      o     the Company's ability to manufacture, market, and price the Battery
            Brain product;

      o     the Company's ability to hire and maintain the personnel necessary
            to run the operations of the Company;

      o     the level of consumer spending for the Company's product;

      o     the success of the Company's marketing and promotion programs in
            obtaining market acceptance for its product;

      o     market conditions affecting the prices of the Company's product; and

      o     responsiveness of both the trade and consumers to the Company's new
            product and marketing and promotion programs.

                                     PART I
ITEM 1. DESCRIPTION OF BUSINESS

Datigen.com, Inc. (the "Company" or "we") has substantially shifted the focus of
its business following a change in control of the Company in November, 2004. As
discussed below, in November, 2004, a majority of the Company's common stock was
purchased by Amir Uziel and six other non-affiliated individuals, and the
Company's then directors and officers resigned and were replaced by Mr. Uziel.
Since then, the Company has ceased operating in the trip hazard removal service
businesses that it had been operating in prior to such change in control.
Instead, the Company has focused on negotiating the purchase of the assets
related to a product known as the Battery Brain, including, without limitation,
the patent and all other rights to the Battery Brain (the "Battery Brain
Assets"), so that the Company may engage in the manufacturing, distribution, and
sale of the Battery Brain. As further described below, the Battery Brain is a
device that is attached to a motor vehicle battery for the purpose of protecting
the vehicle from battery failure and theft. The Battery Brain has been patented
by its developer and current owner, Purisys, Inc. ("Purisys"), a New Jersey
corporation. As discussed below, on March 23, 2005, the Company acquired the
intellectual property rights and certain other assets from Purisys relating to
the Battery Brain. The Company intends to engage promptly in the manufacturing,
distribution, and sale of the Battery Brain.

The Company's Business Prior to November, 2004

The Company was formed in 1999 as an Utah corporation. Until November, 2004, the
Company had been involved in various activities, including development and
marketing of various internet and internet related products and services,
investment in trust deed notes secured by real property, and providing of
concrete cutting and finishing services to persons seeking to comply with
certain provisions of the American Disability Act of 1991 that require the
removal of "trips hazards" from public sidewalks and ramps.

                                        2
<PAGE>

The Trip Hazard Removal Services

On January 2, 2002, the Company paid $200,000 in cash and issued 175,000 shares
of restricted common stock to trusts owned by M. Ballard Gardner and his wife
Lola Gardner of Orem, Utah, in exchange for substantially all the assets Mr.
Gardner owned in the business of trip hazard removal and concrete cutting. The
Company did not acquire any of Mr. Gardner's receivables or assume any of his
pre-existing liabilities. There was no relationship or affiliation between the
Company and Mr. Gardner prior to the transaction. As a result of the
transaction, 175,000 shares of the Company's common stock, representing 20.59
percent of the outstanding shares, were issued to Mr. Gardner.

The assets acquired consisted primarily of equipment and supplies used in the
trip hazard removal business, ongoing customer accounts, and methods of
operation. The excess purchase price over equipment and supplies was allocated
to goodwill. The Company intended to pursue the business of trip hazard removal
in Utah, and use Utah as a base to expand operations to other metropolitan areas
through company and independent operator-owned businesses through its franchise
program. The Company developed this business under the service name "Precision
Concrete Cutting." By December 31, 2003, the Company had seven franchise
operations. Until the spin-off of the concrete cutting business on November 9,
2004, the Company had 8 franchise operations.

The Company offered trip hazard removal services to public and private entities.
The American Disability Act of 1991 ("ADA") requires removal of trip hazards
from all public sidewalks and ramps. The ADA applies to all federal, state,
county and municipal facilities. A trip hazard is defined in the Act as any
vertical change over one-quarter inch at any joint or crack in sidewalks and
ramps. Private property owners also have a need for trip hazard removal to
mitigate potential liability for personal injury resulting from obvious trip
hazards on their property.

The Company marketed a concrete cutting and finishing service to municipalities,
apartment owners, churches, hospitals, educational institutions, etc. The
cutting system used was developed by M. Ballard Gardner, and uses a hand-held
saw to cut through the concrete at the point of the hazard to angle off the
vertical edge, and a grinder is then applied to finish the newly cut surface of
the concrete. Mr. Gardner developed the cutting system in 1991, and had been
successfully using it to service state, county, and municipal facilities, as
well as private entities in Utah. The primary selling points of the Company's
system were that it:

                                       3
<PAGE>

o     required less time to remove the trip-hazard;

o     left a uniform finish on the concrete surface that has been cut;

o     was a long term solution to the trip-hazard problem; and

o     was a cost effective solution, particularly for governmental entities that
      operate on tight budgets.

Other methods of trip hazard removal include the use of grinders, concrete
planers, and scablers to grind down the vertical edge, or require removal and
replacement of the affected area of the sidewalk or ramp. However, only grinding
down the vertical edge leaves a rough unfinished surface, and is potentially
damaging to the underlying concrete, thus creating a more expensive maintenance
problem. The Company's cutting system allowed the Company to finish the surface
and substantially reduces the risk of damage to the concrete as it places less
stress on the concrete slab than grinding. Removing and replacing the affected
area is a long-term solution, but it is more costly and time consuming.
Consequently, the Company did not believe that there was any other method of
trip hazard removal that offered the full range of benefits offered by our
cutting system.

Marketing the Trip Hazard Removal Services

The Company offered its services under the service name "Precision Concrete
Cutting." The Company made personal service calls on prospective clients as well
as meeting them at tradeshows. Prospective clients included federal, state,
county, and municipal facilities, including school districts and universities.
The Company was successful in bidding on government contracts because its
cutting system is a low cost, long-term solution for government entities. The
Company also marketed its services to churches and private businesses.

Each trip hazard removal project was bid separately on the basis of the number,
size, and complexity of the hazards to be removed. The average cost of removing
a one-quarter inch trip hazard on a standard sidewalk is approximately $48, and
usually requires approximately one-half hour of labor to complete.

The Company had a trademark for the name "Precision Concrete Cutting," which was
accepted on the supplemental register.

Franchising

The Company's objective prior to November, 2004, was to refine its method of
operation and system for marketing the franchise opportunity. The Company
believed franchises are popular among persons who desire to own and operate
their own business, because it provides to them the equipment and a system for
starting a business without the time and expense of identifying and developing a
business concept. During 2003, the Company successfully sold two franchises in
the following areas: Seattle, Washington and San Francisco, California. Total
franchises in operation at December 31, 2003 were seven. As of November 9, 2004,
total franchises in operation were eight.

                                       4
<PAGE>

Our franchise offering included:

o the equipment necessary for the trip hazard removal business, except for the
vehicle the franchisee will need to transport equipment from job to job;

o marketing information and materials, including a system for estimating and
bidding trip hazard removal projects, as well as a piece work accounting system;

o a minimum of two weeks of initial training on how to operate the system; and

o ongoing support and training.

During 2004 our standard franchise fee was $95,000. We charged a continuing
monthly royalty of four percent of gross sales, excluding taxes, once the
franchise reaches gross sales equal to the franchise fee. The franchise is for
an initial term of 10 years and has specific territorial rights. The franchise
agreement provided us with the right to terminate a franchisee for a variety of
reasons, including insolvency or bankruptcy, failure to operate according to
certain standards, understatement of gross sales, failure to pay fees, or
material misrepresentation on an application for a franchise.

Competition in the Trip Hazard Removal Industry

In Utah, the Company competed in providing the trip hazard removal services with
other independently owned businesses that provide concrete grinding and
replacement. There were a significant number of these businesses, particularly
in the Salt Lake City and surrounding metropolitan areas, fragmenting the
competitive market. Some of these businesses may have had greater financial,
operational, and managerial resources than us. The Company competed with these
other businesses for trip hazard removal business on the basis of cost and
service.

There were a substantial number of established regional, national, and
international franchise companies that offered a wide variety of business
opportunities to persons seeking to own and operate their own businesses.
Virtually all of these companies had well known and successful franchise
systems, that made these companies and their franchise opportunities
substantially more attractive to many prospective franchisees than that of the
Company. The Company intended to compete on the basis of cost and the profile of
the business owner sought. The Company's franchise opportunity had substantially
lower cost of getting started than many franchises, because its trip hazard
removal business can be operated from home with a pick-up truck and trailer so
there is no need to make substantial capital expenditures to establish a
business location and operation. The Company's franchised business is fairly
simple to operate, so the Company targeted prospective franchisees that are not
interested in businesses that require substantial management experience or
capability to operate successfully.

                                       5
<PAGE>


Government Regulation of Trip Hazard Removal Services

      The business of removing trip hazards is not subject to any meaningful
government regulation. The Company franchise sales program was subject to
Federal Trade Commission regulations and various state laws regulating the offer
and sale of franchises. The FTC and various state laws required the Company to
furnish to prospective franchisees a franchise offering circular containing
prescribed information. Fifteen states required registration of a franchise
offering circular or a filing with state authorities. Substantive state laws
that regulated the franchisor-franchisee relationship existed in a substantial
number of states, and bills had been introduced in Congress from time to time,
which provided for federal regulation of the franchisor-franchisee relationship
in certain respects. The state laws often limited the duration and scope of
non-competition provisions and the ability of a franchisor to terminate or
refuse to renew a franchise, and may have required us to escrow franchise fees
until we provided all equipment, materials, and service offered to the Company's
franchisees to start their business. In 2004, the Company was registered to
offer and sell franchises in two of the 15 states requiring registration, and
completed an offering circular that complies with FTC regulations.

Disposition of Assets

On or about November 8, 2004, the Company conveyed all of its assets relating to
the concerte cutting business and transferred all of its liabilities to a
Precision Concrete Cutting, Inc., a Utah corporation ("PCC"). PCC was an
affiliated corporation owned by all of the then shareholders of the Company. The
conveyed assets included the Company's checking and savings accounts, accounts
receivables, equipment, goodwill, intellectual property, and all other assets of
the Company. PCC assumed all the liabilities of the Company as of said date. The
consideration for such conveyance was the issuance of 601,190 shares of the
common stock of PCC to the Company. These restricted shares were then
distributed to the shareholders of the Company as of November 19, 2004.

PCC agreed to indemnity the Company and its affiliates from any liabilities and
expenses which may arise in connection with the ownership or operation of any of
the assets or business of PCC, including without limitation any obligations
arising from any liability of PCC assumed from the Company or related to the
former business of the Company.

The Company's Business Since November, 2004

On November 24, 2004, 50.87% of the Company's outstanding common stock was
purchased by Amir Uziel and six unaffiliated foreign individuals from certain of
the Company's shareholders, including its then Chief Executive Officer, Joseph
Ollivier (the "Uziel Stock Purchase"). The persons serving as directors and
officers of the Company prior to such transaction subsequently resigned from
their positions with the Company. As a result of such transaction, Mr. Uziel
held directly 30% of the issued and outstanding share capital of the Company and
was elected President, Chief Executive Officer, and director, thereby assuming
control of the Company.

                                       6
<PAGE>


Since such change in control, the Company has sought to accomplish the purchase
of the Battery Brain Assets. The Battery Brain is a small, box-shaped device,
whose size and weight is comparable to that of a cellular phone. It attaches to
the battery of a motor vehicle and performs two principal functions for the
motor vehicle: prevention of battery failure and protection from theft. If the
Battery Brain is attached to a car battery, and the car's operator leaves the
lights on while the car is turned off, the Battery Brain will prevent the
battery from failing, so that the car can be started again without having to
recharge such battery. It works by preventing a battery from becoming drained
below the level necessary for it to function. The Battery Brain is able to
detect when the battery has reached such point and, upon such detection, it
automatically disconnects the power from the battery so that the battery will
not be drained any further. In addition, the Battery Brain protects the vehicle
from being stolen by stopping the battery from powering the engine while the car
is turned off, thereby preventing a potential thief from "hot wiring" the
engine, a procedure commonly used by thieves to turn on the vehicle's engine
without an engine key. The Battery Brain can be used on all types of motor
vehicles, from passenger cars to light trucks to heavy trucks, buses, tractors,
RVs, motorcycles, boats, handicap vehicles or any other motor vehicles that rely
on batteries.

Acquisition of the Battery Brain

On December 15, 2004, the Company and Purisys entered into a binding letter of
intent (the "Letter of Intent") which provided, among other things, for the sale
to the Company of the Battery Brain Assets. The purchase price to be paid by the
Company was to be (i) $100,000 (the "Cash Consideration"), and (ii) the number
of shares of common stock, no par value, of the Company which will constitute
twenty (20%) percent of all issued and outstanding shares on a fully diluted
basis when there has been $1 million invested in the Company, or such earlier
date as agreed upon between the Company and Mr. Levinas (the "Equity
Consideration"). The Letter of Intent obligated the Company to advance $100,000
plus $20,000 towards payment of the Cash Consideration (the "Advance"). If the
Company terminated the Letter of Intent prior to the closing of the purchase,
the Advance will be automatically converted into a loan from the Company to
Purisys, which will become due and payable by Purisys within 15 days after the
date of termination of the Letter of Intent. One of the several closing
conditions was the receipt of equity investments of not less than $900,000 which
would be invested in the development and marketing of the Battery Brain Product

On December 27, 2004, the Company received an aggregate of $178,667 in cash and
executed subscription agreements from 31 persons relating to the purchase of an
aggregate of 35,733,333 shares of common stock at a per share purchase price of
$0.005 per share. The shares were offered and issued pursuant to Regulation S
promulgated by the Securities and Exchange Commission. Of the gross proceeds
received by the Company, $120,000 was paid to Purisys as payment of the Advance
required by the Letter of Intent.

                                       7
<PAGE>

A subsequent net amount of $4,950 was received by the Company in January 2005
relating to the purchase by a non-U.S. citizen of 66,667 shares at a per share
purchase price of $0.075 per share and an additional net amount of $19,975
relating to the purchase by another non-U.S. citizen in March 2005 of 533,333
shares of common stock at a per share purchase price of $0.15 per share. The
shares were offered and issued pursuant to Regulation S promulgated by the
Securities and Exchange Commission.

The Company is currently raising capital through the sale of units, each unit
consisting of one share of common stock, one Class A warrant giving the holder
the right to purchase 1 share of stock at $0.45, which is exercisable for 1 year
from the date of issuance, and one Class B warrant giving the holder the right
to purchase 1 share of stock for $0.75, which is exercisable for 3 years. Each
unit is being offered for $0.20 per unit. As of March 30, 2005, the Company has
received subscriptions totaling an aggregate of $204,914 in net proceeds
representing the issuance of 1,025,000 units. The units are being offered and
issued pursuant to Regulation S promulgated by the Securities and Exchange
Commission.

On February 28, 2005, the Company and Purisys amended the Letter of Intent to
provide that we would advance an additional $170,000 to Purisys to cover
day-to-day operations, finalize the purchase of 5,000 retail package units and
commence the purchase of 5,000 wholesale package units. These units and all
rights associated with these units, including without limitation, revenues from
the sales of these units, will be part of the assets to be purchased by the
Company. The sum of $170,000, plus the previous amount of $120,000 paid to
Purisys pursuant to the Letter of Intent, was to reduce the $900,000 equity
investment required in the Company at the time of closing the transaction
between the parties.

As of December 31, 2004, the Company had no operations or revenues.

On March 23, 2005, the Company , Purisys and Aharon Y. Levinas ("Levinas")
executed an Asset Purchase Agreement (the "Agreement") pursuant to which we
purchased all the intellectual property relating to the Battery Brain product
and the goodwill associated therewith and certain of the equipment relating to
the product. The consideration paid by us for the assets was the issuance to
Levinas, the sole shareholder of Purisys, of the number of shares of common
stock, no par value, of our common stock which will constitute, when there has
been an aggregate of $1,000,000 invested in the Company, (or such earlier date
as agreed upon between the Company and Levinas) twenty (20%) percent of all
issued and outstanding common stock and $100,000, which was previously paid
pursuant to the Letter of Intent.The purchased assets did not include the
inventory which existed as of March 23, 2005 or the molds for the Battery Brain
(which are currently in Italy and China), which were purchased by us for
$66,487. This provision was intended to replace the obligation in the Letter of
Intent regarding the equity investment of $900,000 in the Company at the time of
the closing of the Battery Brain acquisition.

<PAGE>

                                       8

In addition, within the next two years we agreed to use our best efforts to (a)
consummate an equity raise of not less than $1,500,000 dollars at a post-money
valuation of not less than $12,000,000; provided, that all equity raises within
120 days after March 23, 2005 which are based on a post-money valuation which is
$10,500,000 or greater, shall be counted toward the $1,500,000; or (b) generate
revenue for the Battery Brain product in the aggregate amount of $2,000,000. If
we do not achieve either (a) or (b) at any time on or prior to March 23, 2007,
then Levinas shall be entitled to receive additional shares of common stock
which equals 20% of the outstanding share capital on a fully-diluted basis
(calculated as of said date).

The purchase price paid we paid for the Battery Brain was 20% of the issued and
outstanding share capital of the Company and $100,000 in cash. Since Mr. Levinas
wanted to ensure that we would have sufficient funds to expand our distribution
of the Battery Brain, we further agreed that Mr. Levinas will be entitled to an
additional 20% of the shares if within 90 days after the closing $400,000 was
not invested in the Company. This was meant as an incentive for us to raise
funds so as not to have to issue Mr. Levinas the additional 20% equity. As of
April 18th, approximately one month after the closing of the acquisition, said
amount was invested and Mr. Levinas was no longer entitled to said additional
20%.

Mr. Levinas did not desire to have the product which he invented and sold for
over _7_ years being sold to a company that did not have sufficient resources to
mass produce and market the Battery Brain. Recognizing that we did not have
sufficient resources while at the same time believing that the Battery Brain
could become a successful product if further developed in a public company, Mr.
Levinas was willing to sell us the Battery Brain as long as we provided him with
some assurances that either the financial resources would exist, or we would
generate a sufficient amount of sales within two years. Accordingly, we
committed that within two years from the closing, we would either generate no
less than $2 million in sales or will have raised not less than $1.5 million on
a post-money valuation of not less than $12 million. This provision was required
by Mr. Levinas to create a draconian incentive to us to ensure that sufficient
monies would be raised or sales would be generated. Although Mr. Levinas is our
Chief Technology Officer, he has no responsibility for raising capital or
generating sales; his responsibilities are focused on the design and manufacture
of the product.

Furthermore, Mr. Levinas did not desire that we raise money at a low valuation
for the sole purpose of raising cheap capital. He wanted to ensure that the
company valuation after the investments were made was not less than $12 million,
but appreciating that early investors might consider investing but at a lower
valuation than $12 million, Mr. Levinas granted us the right to raise funds for
four months after closing at a $10,500,000 valuation. The valuation of the
company was less important to Mr. Levinas as the capital raise, as evident by
the fact that there was no minimum valuation imposed on the Company for the
initial $1 million capital raise. Accordingly, within three months subsequent to
closing, $1,000,000 was invested. Accordingly, this provision has been
eviscerated and has no further force and effect. Mr. Levinas is currently not
entitled to any further share issuances pursuant to the terms of the purchase
agreement.

                                       9
<PAGE>


We agreed with Levinas to mutually agree to negotiate, in good faith, an
agreement regarding the registration rights of the Levinas for the shares issued
to Levinas pursuant to the Agreement; Levinas shall be entitled to equal
registration rights with our controlling shareholders, pro rata in accordance
with their holdings, subject to a lock-up agreement. The shares will be issued
to Levinas as soon as we are duly authorized to do so.

The only liabilities we assumed in the transaction are (i) the warranties and
service of any Battery Brain products sold prior to the execution and delivery
of the Agreement, (ii) any potential claims made by a person who alleges that he
assisted in developing the Battery Brain product and (iii) any taxes incurred as
a result of the Agreement. If there are any taxes imposed on Purisys and/or
Levinas as a result of the receipt of our shares, we agreed to lend them the
amount of liabilities and expenses owed as a result thereof. Said loan shall be
for a period of not less than 10 years.

Pursuant to the terms of the Agreement, our Board of Directors shall consist of
five (5) members, and Levinas shall be entitled to appoint 40% of the
representatives to the Board of Directors.

We are currently actively manufacturing, marketing, distributing and selling the
Battery Brain, and . as of June 30, 3005, we have sold 1,962 units of the
Battery Brain. If for any reason we cease to manufacture, sell or otherwise
cease to be involved in the Battery Brain product, then Levinas shall have the
right to purchase the Battery Brain product from us; the price and other terms
of such right shall be negotiated. If the parties cannot mutually agree upon a
price, presumably the parties would either (i) continue to negotiate between
themselves as the appropriate price, (ii) obtain a third party appraisal of the
value of the Battery Brain or (iii) seek another purchaser to ascertain the
market price a willing and able buyer would purchase the Battery Brain.

The asset acquisition was consummated in accordance with Section 368(a)(1)(C) of
the Internal Revenue Code of 1986, as amended, as a tax-free reorganization.

Current Business Developments

The target customer for the Battery Brain is the owner of any motor vehicle
requiring a battery to start the vehicles engine. We are currently in the
process of identifying target segments for the Battery Brain product, the
appropriate pricing models and seeking sales representatives and distribution
and channel partners.

                                       10

<PAGE>

      We are investing more then $500,000 in our marketing/sales support
materials, processes and system. We have engaged two marketing firms to build
the marketing/sales material required to attract and support major automotive
channel partners. Other then marketing the primary investment that the company
will make as we build this network is in our inventory. We plan to have a two
month supply on hand and one month in transit by the end of 2005 we would have
over $300,000 invested in inventory.

The electronic components required for our assembly are readily available in the
marketplace. Without any cost to us, we have expanded our manufacturing
capability in China from an annual capacity of 10,000 units to 50,000. The
Company has purchased redesigned manufacturing molds that expand production of
the product. Our facility has additional capacity of 250,000 units which is
available from the manufacturer with only a resource hiring and training cost
that the manufacturer will cover from the increased production volume. Although
we are currently seeking a Chief Executive Officer and/or President, we have in
place the infrastructure necessary to manufacture, distribute and sell the
Battery Brain.

In addition, we are creating an international distribution network through the
execution of distribution agreements. We currently sell the Battery Brain
product to four distributors, one in the Netherlands, one in Israel and two in
the United States. These distributors represent different market segments, as
one deals primarily with the U.S. custom van market, another provides products
for catalog sales and one is a battery manufacturer. The selling price of one
unit ranges from $18 to $70, depending on the model and quantities purchased by
the distributor. Initial commitments from our first three distributors are for
8,000 units.

In 2004, Purisys sold a total of 2,119 units. In the four month period
subsequent to our purchase of the Battery Brain, we sold 2,122 units, generating
an aggregate of $57,000 of revenues.

The product return rate of the Battery Brain sold by Purisys was less than 0.3%.
Although we have only been selling the product for approximately five months,
our product return rate is 0.1%. The company anticipates a profitable endeavor
when we can drive sales of 10,000 units a month .

                                       11

<PAGE>

The Company expects to have a competitive advantage over competitors having
products which the market might consider to be similar to the Battery Brain. We
feel that the Battery Brain is differentiated from similar products offered by
such competitors in a various important ways. The Battery Brain is the only
product of its kind that will protect vehicles from battery failure due to the
operation of any electrical accessory, including headlights, radios, trunk
lights, interior lights, door lights, or due to unknown shorts in the electrical
system. Similar products offered by competitors protect vehicles from battery
failure due only to the operation of the headlights. The Battery Brain is also
easier to install than other competitive products. Further, In order to reset
the load (the energy source), most other competitive products require the
operator of the vehicle to lift the hood, locate the device, and press a reset
knob located on the device. The Battery Brain can be operated via a remote
control.

The patent for the Battery Brain does not expire until July 23, 2022. The
Company is not dependent upon a small number of suppliers for the raw materials
used in the production of the Battery Brain as it expects to have alternative
sources available and not to encounter any difficulties in obtaining such raw
materials. We will not dependent upon a small number of customers, as we intend
to market the Battery Brain to all users of motor vehicles.

Employees

While the Company was still engaged in the trip hazard removal business until
November 2004, the Company employed four to eight persons on an hourly or
part-time basis to perform concrete cutting and hazard removal services at the
facilities of the Company's clients. As a result of the acquisition of the
Battery Brain product, Levinas was appointed as the Chief Technology Officer. We
are actively seeking a candidate to become our Chief Executive Officer.

We agreed to employ Levinas for a 4-year term, with a base salary of $160,000,
$200,000, $240,000 and $240,000 for each year of the term. All benefits to be
granted to the individual who will be appointed as our Chief Executive Officer
shall be granted to Levinas as well, including bonuses and stock options.
Levinas shall receive a cell phone and a car allowance. Pursuant to the terms of
the Consulting Agreement, Levinas is subject to standard confidentiality and
non-compete provisions.
The consulting agreement with Levinas provides that if Levinas is terminated
during the 4-year term, or is no longer employed by us for any reason during
said period, including termination for cause or death, we remain obligated to
pay the full amount of payment due Levinas thereunder.

ITEM 8A.  CONTROLS AND PROCEDURES

Based on an evaluation under the supervision and with the participation of the
Company's management as of the end of the period covered by this Annual Report
on Form 10-KSB, the Company's chief financial officer has concluded that the
Company's disclosure controls and procedures (as defined in Rules 13a-14(c) and
15d-14(c) under the Securities Exchange Act of 1934, as amended (Exchange Act)
are effective to ensure that information required to be disclosed by the Company
in reports that it files or submits under the Exchange Act is recorded,
processed, summarized and reported within the time periods specified in
Securities and Exchange Commission rules and forms.

                                       12
<PAGE>


There were no significant changes in the Company's internal controls or in other
factors that could significantly affect these controls subsequent to the date of
their evaluation. There were no significant deficiencies or material weaknesses,
and therefore there were no corrective actions taken. However, the design of any
system of controls is based in part upon certain assumptions about the
likelihood of future events and there is no certainty that any design will
succeed in achieving its stated goal under all potential future considerations,
regardless of how remote.




                                       13
<PAGE>



                                   SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the Company has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.

                             DATIGEN.COM, INC.

Dated: August 10, 2005       By: /s/ Edward Braniff
                                 ------------------
                             Name: Edward Braniff

                             Title: Chief Financial

                             Officer (principal executive and financial officer)




                                       14

<PAGE>

                              DATIGEN.COM, INC.
                         (A Development Stage Company)

                              FINANCIAL STATEMENTS

                     Years Ended December 31, 2004 and 2003
                    and for the Period from Inception of the
        Development Stage on November 24, 2004, through December 31, 2004
                                   (Amended)

      TABLE OF CONTENTS
                                                                       Page

      Independent Auditor's Report                                      F-2

      Balance Sheet                                                     F-3

      Statements of Operations                                          F-4

      Statements of Stockholders' Equity                                F-5

      Statements of Cash Flows                                          F-6

      Notes to Financial Statements                                     F-7



                                      F-1

<PAGE>

Squire & Company; PC [Logo]
Certified Public Accountants and Business Consultants
--------------------------------------------------------------------------------

                          INDEPENDENT AUDITOR'S REPORT

The Board of Directors
of Datigen.com, Inc.
(A Development Stage Company)

We have audited the accompanying balance sheet of Datigen.com, Inc. (a
development stage company) as of December 31, 2004, and the related statements
of operations, stockholders' equity, and cash flows for each of the years in the
two-year period ended December 31, 2004, and for the period from inception of
the development stage on November 24, 2004, through December 31, 2004. These
financial statements are the responsibility of the Company's management. Our
responsibility is to express an opinion on the financial statements based on our
audits.

We conducted our audits in accordance with auditing standards of the Public
Company Accounting Oversight Board (United States of America). Those standards
require that we plan and perform the audits to obtain reasonable assurance about
whether the financial statements are free of material misstatement. The Company
is not required to have, nor were we engaged to perform, an audit of its
internal controls over financial reporting. Our audits included consideration of
internal control over financial reporting as a basis for designing our
procedures that are appropriate in the circumstances, but not for the purpose of
expressing an opinion on the effectiveness of the Company's internal control
over financial reporting. As such we express no such opinion. An audit includes
examining, on a test basis, evidence supporting the amounts and disclosures in
the financial statements. An audit also includes assessing the accounting
principles used and significant estimates made by management, as well as
evaluating the overall financial statement presentation. We believe that our
audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in
all material respects, the financial position of Datigen.com, Inc. (a
development stage company) as of December 31, 2004, and the results of its
operations and its cash flows for each of the years in the two-year period ended
December 31, 2004, and for the period from inception of the development stage on
November 24, 2004, through December 31, 2004, in conformity with accounting
principles generally accepted in the United States of America.

As discussed in Note10 to the financial statements, management has amended the
financial statements to include disclosures related to "a development stage
company." Such disclosures have had no impact on previously reported amounts.

/s/ Squire & Company, PC
------------------------
Orem, Utah
April 6, 2005
(except for Note 10, as to which the date is August 9, 2005)

                                      F-2
<PAGE>

DATIGEN.COM, INC.
(A Development Stage Company)
BALANCE SHEET
December 31, 2004
--------------------------------------------------------------------------------

ASSETS

Current Assets:
   Cash                                                             $    58,132
                                                                    -----------
      Total current assets                                               58,132

Advance Toward Purchase of Battery Brain Product                        120,000
                                                                    -----------
      Total assets                                                  $   178,132
                                                                    ===========

LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities:
   Accounts payable                                                 $     1,525
                                                                    -----------
      Total current liabilities                                           1,525
                                                                    -----------

Stockholders' Equity:
   Common stock, no par value,  50,000,000 shares authorized          1,092,782
   Accumulated deficit prior to development stage                      (913,198)
   Deficit accumulated during the development stage                      (2,977)
                                                                    -----------
      Total stockholders' equity                                        176,607
                                                                    -----------
         Total liabilities and stockholders' equity                 $   178,132
                                                                    ===========

The accompanying notes are an integral part of this financial statement.


                                      F-3
<PAGE>

DATIGEN.COM, INC.
(A Development Stage Company)
STATEMENTS OF OPERATIONS
--------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                                              From inception of the
                                                                                 development stage
                                                  Years Ended December, 31       on November 24,
                                               -----------------------------      2004, through
                                                   2004             2003        Decemer 31, 2004
                                               -----------       -----------       -----------
<S>                                            <C>               <C>               <C>
General and Administrative Expenses            $     2,977       $        --       $     2,977
                                               -----------       -----------       -----------

Loss From Continuing Operations                     (2,977)               --            (2,977)
                                               -----------       -----------       -----------

Discontinued Operations
   Income from discontinued operations
      before income tax expense (benefit)          156,014             8,553                --
   Income tax expense (benefit)                     44,854            (7,306)               --
                                               -----------       -----------       -----------
      Income from discontinued operations          111,160            15,859                --
                                               -----------       -----------       -----------

Net Income (Loss)                              $   108,183       $    15,859       $    (2,977)
                                               ===========       ===========       ===========

Earnings Per Share -
   Basis and Fully Diluted
   Loss from continuing operations             $        --       $        --
   Income from discontinued operations                0.09              0.02
                                               -----------       -----------
      Net income
                                               $      0.09       $      0.02
                                               ===========       ===========

Weighted Average Shares Outstanding              1,149,355           860,000
</TABLE>

The accompanying notes are an integral part of this financial statement.


                                      F-4
<PAGE>

DATIGEN.COM, INC.
(A Development Stage Company)
STATEMENTS OF STOCKHOLDERS' EQUITY
Years Ended December 31, 2004 and 2003
--------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                                                        Accumulated     Accumulated
                                                                        Cumulative     Deficit Prior   Deficit Prior
                                               Common Stock               Other           to the          to the
                                       ----------------------------   Comprehensive    Developoment    Developoment
                                         Shares           Amount           Income         Stage            Stage         Total
                                       ------------    ------------    ------------    ------------    ------------    ------------
<S>                                    <C>             <C>             <C>             <C>             <C>             <C>
Balance, January 1, 2003                    860,000    $  1,236,600    $    (50,000)   $    (56,327)   $         --    $  1,130,273

Comprehensive net income calculation:
   Net income                                    --              --              --          15,859              --          15,859
   Other comprehensive loss:
      Recognized loss on marketable
       securities                                --              --          50,000              --              --          50,000
                                       ------------    ------------    ------------    ------------    ------------    ------------

      Comprehensive net income                   --              --          50,000          15,859              --          65,859
                                       ------------    ------------    ------------    ------------    ------------    ------------

Balance, December 31, 2003                  860,000       1,236,600              --         (40,468)             --       1,196,132


Repurchase of common stock                 (258,810)       (323,401)             --              --              --        (323,401)

Issuance of common stock for cash,
   December 2004, $0.005 per share       35,916,666         179,583              --              --              --         179,583

Distribution of shares of subsidiary
   to shareholders, November 19, 2004            --              --              --        (983,890)             --        (983,890)

Net income                                       --              --              --         111,160          (2,977)        108,183
                                       ------------    ------------    ------------    ------------    ------------    ------------

Balance, December 31, 2004             $ 36,517,856    $  1,092,782    $         --    $   (913,198)   $     (2,977)   $    176,607
                                       ============    ============    ============    ============    ============    ============
</TABLE>


The accompanying notes are an integral part of this financial statement.

                                      F-5

<PAGE>

DATIGEN.COM, INC.
(A Development Stage Company)
STATEMENTS OF CASH FLOWS
--------------------------------------------------------------------------------
<TABLE>
<CAPTION>

                                                                                                               From inception of the
                                                                                                                development stage
                                                                                     Years Ended December, 31     on November 24,
                                                                                    -------------------------      2004, through
                                                                                      2004            2003        Decemer 31, 2004
                                                                                    ---------       ---------         ---------
<S>                                                                                 <C>             <C>               <C>
Cash Flows from Operating Activities
   Net income (loss)                                                                $ 108,183       $  15,859         $  (2,977)
   Less income from discontinued operations                                          (111,160)        (15,859)               --
                                                                                    ---------       ---------         ---------
   Loss from continuing operation                                                      (2,977)             --            (2,977)
   Adjustments to reconcile loss from continuing operation to net cash used by
      operating activities of continuing operations:
         Increase in accounts payable                                                   1,526              --             1,526
                                                                                    ---------       ---------         ---------
         Net cash used by operating activities of continuing
           operations                                                                  (1,451)             --            (1,451)

         Net cash provided by operating activities of
           discontinued operations                                                    154,009          99,475                --
                                                                                    ---------       ---------         ---------

         Net cash provided (used) by operating activities                             152,558          99,475            (1,451)
                                                                                    ---------       ---------         ---------

Cash Flows from Investing Activities:
   Advance toward purchase of Battery Brain product                                  (120,000)             --          (120,000)

      Net cash used by investing activities of
         discontinued operations                                                      (95,000)         (1,521)               --
                                                                                    ---------       ---------         ---------

      Net cash used by investing activities                                          (215,000)         (1,521)         (120,000)

Cash Flows from Financing Activities
   Proceeds from issuance of common stock                                             179,583              --           179,583
   Repurchase of common stock                                                        (323,401)             --                --
   Cash distributed to shareholders with stock of subsidiary                          (80,050)             --                --
                                                                                    ---------       ---------         ---------

      Net cash provided (used) by financing activities                               (223,868)             --           179,583
                                                                                    ---------       ---------         ---------

Net Increase (Decrease) in Cash                                                      (286,310)         97,954            58,132

Cash at Beginning of Period                                                           344,442         246,488                --
                                                                                    ---------       ---------         ---------

Cash at End of Period                                                               $  58,132       $ 344,442         $  58,132
                                                                                    =========       =========         =========
</TABLE>


                                      F-6


 DATIGEN.COM, INC.
(A Development Stage Company)
NOTES TO FINANCIAL STATEMENTS
--------------------------------------------------------------------------------

Note 1.  Summary of Significant Accounting Policies

This summary of significant accounting policies of Datigen.com, Inc. (the
Company) is presented to assist in understanding the Company's financial
statements. The financial statements and notes are representations of the
Company's management, which is responsible for their integrity and objectivity.
These accounting policies conform to accounting principles generally accepted in
the United States of America and have been consistently applied in the
preparation of the financial statements.

Nature of Operations - Datigen.com, Inc., formerly Atomic Giant.com, Inc., was
incorporated in the State of Utah on February 10, 1999, for the purpose of
developing and marketing various Internet and Internet-related products and
services. Until January 1, 2002, the Company was considered to be in the
developmental stage in accordance with SFAS No. 7.

On January 2, 2002, the Company purchased the assets of Amerex, a sole
proprietorship. The Company paid $200,000 cash and issued 175,000 shares of
common stock for property and equipment valued at $12,695 and goodwill of
$344,805. As a result of the Amerex purchase, the Company became the franchisor
of trip hazard operations and sold machinery, saw blades and related products
directly to franchisees. As described in Note 2, the Company discontinued this
business on November 19, 2004 through a series of transactions whereby all of
the assets and liabilities of this concrete-cutting business were transferred to
a newly-formed subsidiary of the Company, and the stock of that subsidiary was
distributed to the shareholders of the Company. Immediately subsequent to this
transaction, the Company owned no assets and had no liabilities.

On November 24, 2004, certain shareholders of the Company, including its chief
executive officer, entered into a Purchase and Sale Agreement which provided,
among other things, for the sale of 50.87% of the outstanding stock of the
Company to a new group of shareholders. In connection with this transaction, all
outstanding options to purchase stock of the Company were cancelled. Also, in
connection with these changes, a new board of directors was appointed and
control of the Company changed to a new group of shareholders and management. In
conjunction with these activities, the Company was reclassified as a development
stage company. From November 24, 2004 through December 31, 2004, Company sales
have not been sufficient to sustain operations, and the Company relied upon cash
flows from financing activities to sustain operations. Accordingly, the Company
is considered to be in the development stage. Management believes future
operations will provide sufficient cash flows for the Company to continue as a
going concern. These financial statements do not include any adjustments
relating to the recoverability and classification of recorded asset amounts or
the amounts of liabilities that might be necessary if the Company is unable to
continue as a going concern.

Concentration of Credit Risk - As of December 31, 2004, all of the Company's
cash is held in trust by the Company's outside legal counsel.

                                       F-7
<PAGE>

DATIGEN.COM, INC.
(A Development Stage Company)
NOTES TO FINANCIAL STATEMENTS
--------------------------------------------------------------------------------

Note 1.  Summary of Significant Accounting Policies (Continued)

Earnings Per Share - The computation of basic earnings per common share is based
on the weighted average number of shares outstanding during each period.

The computation of diluted earnings per common share is based on the weighted
average number of shares outstanding during the year plus the common stock
equivalents which would arise from the exercise of stock options and warrants
outstanding using the treasury stock method and the average market price per
share during the year.

Accounting Estimates - The preparation of financial statements in conformity
with generally accepted accounting principles requires management to make
estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenues and expenses
during the reporting period. Actual results could differ from those estimates.

Stock Based Compensation - The Company did not grant any stock options to
employees during the years ended December 31, 2004 or 2003, and all outstanding
stock options were cancelled on November 24, 2004. The Company has adopted the
disclosure-only provisions of Statement of Financial Accounting Standards (SFAS)
No. 123, "Accounting for Stock-Based Compensation." Accordingly, no compensation
expense has been recognized for stock options granted to employees. But, had
compensation expense for the Company's stock options been determined based on
the fair value at the grant date consistent with the provision of SFAS No. 123,
there also would have been no compensation expense recognized for the years
ended December 31, 2004 or 2003, and the Company's results of operations would
have been the same as reported in the Statements of Income presented herein.

Fair Value of Financial Instruments - The Company's financial instruments
consist of cash and accounts payable. The carrying amounts approximate fair
value because of the short-term nature of the items.

Recent Accounting Pronouncements - In December 2004, the Financial Accounting
Standards Board (FASB) issued Statement of Financial Accounting Standards No.
123R, (SFAS 123R), Share-Based Payment, an amendment of FASB Statements Nos. 123
and 95, which addresses the accounting for share-based payment transactions in
which a company receives employee services in exchange for either equity
instruments of that company or liabilities that are based on the fair value of
that company's equity instruments, or that may be settled by issuance of such
equity instruments. SFAS 123R eliminates the Company's ability to account for
share-based compensation transactions using the intrinsic value method as
prescribed by Accounting Principles Board Opinion No. 25, Accounting for stock
Issued to Employees, and requires that such transactions be accounted for using
a fair value-based method and recognized as expense in the statement of income.
SFAS 123R is effective for the Company beginning January 1, 2006, although early
adoption is encouraged by the statement. The Company is currently


                                      F-8
<PAGE>

DATIGEN.COM, INC.
(A Development Stage Company)
NOTES TO FINANCIAL STATEMENTS
--------------------------------------------------------------------------------


Note 1.  Summary of Significant Accounting Policies (Continued)

Recent Accounting Pronouncements (continued)

evaluating the method and timing of adoption. The Company is also evaluating the
impact that the adoption of SFAS 123R will have on its financial statements. In
November 2004, the FASB issued Statement of Financial Accounting Standards No.
151 (SFAS 151), Inventory Costs, an amendment of ARB No. 43, Chapter 4. The
amendments made by SFAS 151 clarify that abnormal amounts of idle facility
expense, freight, handling costs, and wasted materials (spoilage) should be
recognized as current period charges and require the allocation of fixed
production overhead to inventory based on the normal capacity of the production
facilities. SFAS 151 is effective for inventory costs incurred during fiscal
years beginning after June 15, 2005. The Company does not expect the adoption of
SFAS 151 to have a material impact on its financial condition or results of
operations, although the ultimate impact will depend on its future experience
with idle facilities, freight, handling costs, and wasted materials (spoilage).

In December 2004, the FASB issued Statement of Financial Accounting Standards
No. 153 (SFAS 153), Exchanges of Nonmonetary Assets - an amendment of APB
Opinion No. 29. SFAS 153 amends Opinion 29 to eliminate the exception for
nonmonetary exchanges of similar productive assets and replaces it with a
general exception for exchanges of nonmonetary assets that do not have
commercial substance. A nonmonetary exchange has commercial substance if the
future cash flows of the entity are expected to change significantly as a result
of the exchange. The Company does not expect this pronouncement to have a
material impact on its financial statements.

Note 2.  Discontinued Operations and Distribution to Shareholders

On November 8, 2004, the Board of Directors of the Company resolved to
contribute all of the assets (subject to all of the liabilities) of the
Company's concrete-cutting business to Precision Concrete Cutting, Inc. (PPC), a
newly-formed subsidiary of the Company. The transfer of the assets and
liabilities was in preparation for a distribution of the stock of this
subsidiary to the shareholders of the Company. On November 19, 2004, all of the
shares of PPC were distributed to the shareholders of the Company. Immediately
subsequent to this distribution, the Company had no assets and no liabilities.
PPC agreed to indemnify the Company from any liabilities and expenses which
might arise in connection with the ownership or operation of any of the assets
and business transferred to PPC.

The operations of the concrete-cutting business have been accounted for as
discontinued operations, and accordingly, the results of operations and cash
flows associated with this business have been segregated and reported as
discontinued operations in the accompanying statements of income and cash flows.
All periods presented have been restated to reflect the discontinued operations.

                                      F-9
<PAGE>

DATIGEN.COM, INC.
(A Development Stage Company)
NOTES TO FINANCIAL STATEMENTS
--------------------------------------------------------------------------------

Note 2.  Discontinued Operations and Distribution to Shareholders (Continued)

Information related to the discontinued operations of the concrete-cutting
business is set forth below:

                                        Year ended December 31,
                                     ------------------------------
                                            2004            2003
                                     --------------  --------------
Revenues                               $   643,226       $ 720,869

Direct operating costs                    (270,099)       (425,168)

General and administrative expenses       (249,837)       (269,903)
                                     --------------  --------------

Income from operations                     123,290          25,798

Other income (expense), net                 32,724         (17,245)
                                     --------------  --------------

Income before income taxes                 156,014           8,553

Income tax expense (benefit)                44,854          (7,306)
                                     --------------  --------------
Net income                               $ 111,160        $ 15,859
                                     ==============  ==============

The distribution of the stock of PPC to the shareholders of the Company has been
accounted for by a charge to retained earnings (accumulated deficit) in an
amount equal to the historical book value of the net assets of PPC. The net
assets of PPC at the date of distribution were composed of the following:


Assets
  Cash                                $     80,050
  Accounts receivable                        35475
  Inventories                                50497
  Notes receivable                          486915
  Property and equipment, net                30289
  Goodwill                                  344805
  Deferred income tax asset                  42539
                                      -------------
  Total assets                           1,070,570
                                      -------------

Liabilities
  Accrued expenses                           6,593
  Deferred income tax liability             80,087
                                      -------------
  Total liabilities                         86,680
                                      -------------
  Net assets                          $    983,890
                                      =============

                                      F-10
<PAGE>

DATIGEN.COM, INC.
(A Development Stage Company)
NOTES TO FINANCIAL STATEMENTS
--------------------------------------------------------------------------------

Note 3.  Common Stock

Between January 1, 2004 and November 23, 2004, the Company purchased and retired
258,810 shares of its common stock at an average purchase price of $1.25 per
share.

On December 27, 2004, the Company sold 35,733,333 shares of common stock at
$0.005 per share pursuant to an exemption under Regulation S promulgated by the
Securities and Exchange Commission. Additionally, during December 2004, the
Company sold another 183,333 shares of common stock also at $0.005 per share.
There were no underwriters or broker-dealers involved in the private placement
of the stock, and accordingly there were no underwriting discounts or
commissions. The Company received the full gross proceeds of $179,583 from the
sale of the common stock. Of these shares sold in December 2004, 1,500,000 were
purchased by the new Chief Executive Office of the Company and 50,000 were
purchased by a new Director of the Company.

Note 4.  Purchase of Battery Brain Product

On December 15, 2004, the Company entered into a binding letter of intent with
Purisys, Inc., which provides, among other things, for the sale to the Company
of all of the assets constituting the Battery Brain product owned by Purisys. In
connection with the letter of intent, the Company agreed to advance $100,000
plus $20,000 towards payment of the purchase price. As described in Note 9, the
Company completed the acquisition of the Battery Brain product from Purisys in
March 2005.

Note 5.  Income Taxes

In conjunction with the transfer of net assets of the concrete cutting business
to a newly-formed subsidiary, and the subsequent distribution of the stock of
that subsidiary to the shareholders of the Company on November 19, 2004, the net
operating losses that existed at the date of the distribution were distributed
with the other net assets. As such, at December 31, 2004, the net operating
losses of the Company are $2,977, which is the loss from operations subsequent
to the distribution. These net operating losses expire in 2024. The utilization
of the net operating loss carry forward is dependent upon the tax laws in effect
at the time the net operating loss carry forwards can be utilized.

Note 6.  Supplemental Cash Flow Disclosure

Non-cash investing and financing transactions - As described in Note 2, the
Company distributed the stock of its wholly-owned subsidiary to the Company's
shareholders. The net assets of the subsidiary at the date of distribution
totaled $983,890, including cash of $80,050.

During the years ended December 31, 2003, the Company recorded realized losses
on marketable securities of $50,000.

                                      F-11
<PAGE>


DATIGEN.COM, INC.
(A Development Stage Company)
NOTES TO FINANCIAL STATEMENTS
--------------------------------------------------------------------------------


Note 6.  Supplemental Cash Flow Disclosure (Continued)

Cash paid for interest and income taxes - The Company paid $28 and $100 for
interest and income taxes, respectively, during the year ended December 31, 2003
(none for the year ended December 31, 2004).

Note 7.  Stock Options

The Company has a Stock Option Plan (Option Plan), which provides for the grant
of incentive stock options and non-qualified stock options to employees,
directors and consultants. Incentive stock options may only be granted to
employees. The Option Plan is administered by the Executive Compensation
Committee of the Board of Directors, which determines the terms of options
granted including the exercise price, the number of shares subject to the
option, and the exercisability of the option. However, the new Board of
Directors has no intention of issuing any options under this plan.

In conjunction with the Purchase and Sale Agreement entered into on November 24,
2004, whereby certain shareholders of the Company sold stock constituting 50.87%
of the outstanding stock of the Company to a new group of shareholders, all
outstanding options to purchase stock of the Company were cancelled. As a result
of this cancellation, the Company has no common stock equivalents at December
31, 2004.

The schedule of stock options is as follows:

                                            Number of       Weighted-Average
                                              Options         Exercise Price
                                    ------------------      ------------------
Outstanding at January 1, 2003                 65,000       $       1.38
  Granted                                           -                  -
  Expired                                           -                  -
  Exercised                                         -                  -
  Cancelled                                         -                  -
                                    ------------------
Outstanding at December 31, 2003               65,000       $       1.38
  Granted                                           -                  -
  Expired                                           -                  -
  Exercised                                         -                  -
  Cancelled                                   (65,000)                 -
                                      ----------------
Outstanding at December 31, 2004                    -       $       1.38
                                    ==================


                                      F-12
<PAGE>


DATIGEN.COM, INC.
(A Development Stage Company)
NOTES TO FINANCIAL STATEMENTS
--------------------------------------------------------------------------------


Note 8.  Related Party Transactions

Until November 19, 2004, the Company had a note receivable with a finance
company owned by an officer of the Company. The note had no principal repayment
terms, bore interest at ten percent, and was collateralized by real property. At
November 19, 2004 and December 31, 2003, the balance on the note was $284,295
and $189,295, respectively. On November 19, 2004, this note was part of the
assets contributed to PPC prior to the distribution of the stock of PPC to the
shareholders of the Company, as described in Note 2 to the financial statements.

Note 9.  Subsequent Events

Sale of Common Stock - Subsequent to December 31, 2004, the Company has sold
683,333 shares of common stock at prices ranging from $0.005 to $0.15 per share,
and received net proceeds in the amount of $85,342.

Sale of Units - The Company is currently raising capital through the sale of
units, each unit consisting of one share of common stock, one Class A warrant
giving the holder the right to purchase 1 share of stock at $0.45, which is
exercisable for 1 year from the date of issuance, and one Class B warrant giving
the holder the right to purchase 1 share of stock for $0.75, which is
exercisable for 3 years. Each unit is being offered for $0.20 per unit. As of
March 30, 2005, the Company has received subscriptions totaling an aggregate of
$204,914 in net proceeds representing the issuance of 1,025,000 units. The units
are being offered and issued pursuant to Regulation S promulgated by the
Securities and Exchange Commission.

Purchase of Battery Brain product - On February 28, 2005, the Company and
Purisys amended the Letter of Intent to provide that the Company would advance
an additional $170,000 to Purisys to cover day-to-day operations, finalize the
purchase of 5,000 retail package units and commence the purchase of 5,000
wholesale package units. These units and all rights associated with these units,
including without limitation, revenues from the sales of these units, will be
part of the assets to be purchased by the Company.

                                      F-13
<PAGE>


DATIGEN.COM, INC.
(A Development Stage Company)
NOTES TO FINANCIAL STATEMENTS
--------------------------------------------------------------------------------


Note 9.  Subsequent Events (Continued)

Purchase of Battery Brain product (continued)

On March 23, 2005, the Company , Purisys and Aharon Y. Levinas ("Levinas")
executed an Asset Purchase Agreement (the "Agreement") pursuant to which the
Company purchased all the intellectual property relating to the Battery Brain
product and the goodwill associated therewith and certain of the equipment
relating to the product. The consideration paid for the assets was the issuance
to Levinas, the sole shareholder of Purisys, of the number of shares of common
stock, no par value, of the Company's common stock which will constitute, when
there has been an aggregate of $1,000,000 invested in the Company, (or such
earlier date as agreed upon between the Company and Levinas) twenty (20%)
percent of all issued and outstanding common stock and $100,000, which was
previously paid pursuant to the Letter of Intent. Mr. Levinas has the right to
an additional 20% of the issued and outstanding share capital of the Company if,
prior to June 23, 2005, $400,000 is not invested in the development of the
Company's Battery Brain product. If less than $400,000 is invested, said 20%
shall be pro rated based on the actual amount invested.

In addition, within the next two years the Company agreed to use its best
efforts to (a) consummate an equity raise of not less than $1,500,000 dollars at
a post-money valuation of not less than $12,000,000; provided, that all equity
raises within 120 days after March 23, 2005 which are based on a post-money
valuation which is $10,500,000 or greater, shall be counted toward the
$1,500,000; or (b) generate revenue for the Battery Brain product in the
aggregate amount of $2,000,000. If the Company does not achieve either (a) or
(b) at any time on or prior to March 23, 2007, then Levinas shall be entitled to
receive additional shares of common stock which equals 20% of the outstanding
share capital on a fully-diluted basis (calculated as of said date).

The shares issued to Levinas pursuant to the Agreement were issued in a private
transaction exempt from registration under the Securities Act of 1933, as
amended, in reliance of Section 4(2) of that act. The certificate evidencing the
securities will contain a legend restricting their transferability absent
registration under the Securities Act or the availability of an applicable
exemption therefrom. The purchased assets did not include the inventory which
existed as of March 23, 2005 or the molds for the Battery Brain (which are
currently in Italy and China), which were purchased by the Company for $66,487.

We agreed to issue to Levinas an additional 20% of the issued and outstanding
shares if prior to June 23, 2005 $400,000 is not invested in the development of
the Battery Brain product. If less than $400,000 is invested, said 20% shall be
pro rated based on the actual amount invested.

                                      F-14
<PAGE>


DATIGEN.COM, INC.
(A Development Stage Company)
NOTES TO FINANCIAL STATEMENTS
--------------------------------------------------------------------------------


Note 9.  Subsequent Events (Continued)

Purchase of Battery Brain product (continued)

The only liabilities assumed by the Company in the transaction are (i) the
warranties and service of any Battery Brain products sold prior to the execution
and delivery of the Agreement, (ii) any potential claims made by a person who
alleges that he assisted in developing the Battery Brain product and (iii) any
taxes incurred as a result of the Agreement.

The Battery Brain is a small, box-shaped device, whose size and weight is
comparable to that of a cellular phone. It attaches to the battery of a motor
vehicle and performs two principal functions for the motor vehicle: prevention
of battery failure and protection from theft.

The asset acquisition was consummated in accordance with Section 368(a)(1)(C) of
the Internal Revenue Code of 1986, as amended, as a tax-free reorganization.

In conjunction with the purchase of the Battery Brain product, the Company
agreed to employ Levinas for a 4-year term, with a base salary of $160,000,
$200,000, $240,000 and $240,000 for each year of the term. All benefits to be
granted to the individual who will be appointed as the Company's Chief Executive
Officer shall be granted to Levinas as well, including bonuses and stock
options.

Note 10. Financial Statement Amendment

The financial statements have been amended to reflect disclosures related to
development stage companies. Accordingly, additional information has been
provided in the statements of operations and cash flows for the period from
inception of the development stage on November 24, 2004, through December 31,
2004. The additional information has had no impact on previously reported
amounts.

                                      F-15